| ²é¿´: 174 | »Ø¸´: 1 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
ÍÁ‰Í‰Íľ³æ (Ö°Òµ×÷¼Ò)
¸±¾Ö¼¶Ë®ÎñÏåÀí£¨·Ç80ºó£©
|
[½»Á÷]
ÖÐÎÄÂÛÊöÎÄÕµÄÓ¢ÎÄÕªÒª£¬ÇëÅ£È˰ïæÐÞ¸ÄÏ£¬Ð»ÁË
|
||
|
Ó¢ÎÄˮƽºÜÀã¬ÇëÅ£È˰ïæ¸ã¶¨¡£Ð»ÁËÄúÄÄ¡£ ¡¾ÕªÒª¡¿Í¨¹ý¼òµ¥»Ø¹ËÅÁ½ðɲ¡·¢²¡»úÖÆ¼°È¥·Ö»¯Óë¼²²¡·¢Õ¹¹ØÏµÑо¿ÏÖ×´£¬·ÖÎö¶à°Í°·ÄÜÉñ¾ÔªÈ¥·Ö»¯¿ÉÄÜÐÔ¼°ÆäÔÚÅÁ½ðɲ¡·¢²¡ÖеĿÉÄÜ×÷Óã¬Ìá³ö¶à°Í°·ÄÜÉñ¾ÔªÈ¥·Ö»¯¿ÉÄÜÊÇÅÁ½ðɲ¡Ç±ÔÚ»úÖÆµÄÉèÏë¡£ Abstract After a brief retrospect on the latest advances in pathogenesis of Parkinson¡¯s disease, and in the relationship between dedifferentiation and disease development, the authors analysed the possibility of dedifferentiation of dopaminergic neurons, and its possible role in Parkinson's disease, and then suggested that the dedifferentiation of dopaminergic neurons maybe a new potential mechanism of Parkinson's disease. |
» ²ÂÄãϲ»¶
ÇóÎÄÏ×
ÒѾÓÐ3È˻ظ´
277¹¤¿ÆÇóµ÷¼Á
ÒѾÓÐ7È˻ظ´
µ÷¼Á
ÒѾÓÐ3È˻ظ´
301Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
0703Çóµ÷¼Á383·Ö
ÒѾÓÐ6È˻ظ´
Ó¢Ò»Êý¶þÉúÎïÐÅϢѧ287·Ö£¬±¾¿ÆÉúÎï¿ÆÑ§£¬Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
¿¼Ñе÷¼Á
ÒѾÓÐ5È˻ظ´
081700£¬311£¬Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
0703»¯Ñ§
ÒѾÓÐ7È˻ظ´
363Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´

charleygan
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
chlgan
- ·ÒëEPI: 99
- Ó¦Öú: 496 (˶ʿ)
- ¹ó±ö: 0.005
- ½ð±Ò: 13167.2
- É¢½ð: 15
- ºì»¨: 44
- Ìû×Ó: 2396
- ÔÚÏß: 399.5Сʱ
- ³æºÅ: 859768
- ×¢²á: 2009-09-29
- ÐÔ±ð: GG
- רҵ: Ó¦Óø߷Ö×Ó»¯Ñ§ÓëÎïÀí
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
ÍÁ‰Í‰Í(½ð±Ò+15,VIP+0):²»´í¡£ÉϺüѣ¬´¿Å¨µÄ¡£ 10-18 14:41
ÍÁ‰Í‰Í(½ð±Ò+15,VIP+0):²»´í¡£ÉϺüѣ¬´¿Å¨µÄ¡£ 10-18 14:41
| Based on the latest advances in pathogenesis of Parkinson¡¯s disease and the relationship between dedifferentiation and disease development, the possibility of dedifferentiation of dopaminergic neurons and its possible role in Parkinson's disease were analysed. It's proposed that the dedifferentiation of dopaminergic neurons may be a new potential mechanism of Parkinson's disease. |
2Â¥2009-10-18 14:39:07














»Ø¸´´ËÂ¥